BioTelemetry (BEAT) Tops Q4 EPS by 8c

Go back to BioTelemetry (BEAT) Tops Q4 EPS by 8c

CardioNet (BEAT) PT Raised to $41 at Dougherty & Co

February 23, 2018 8:19 AM EST

Dougherty & Co raised its price target on CardioNet (NASDAQ: BEAT) to $41.00 (from $40.00) while maintaining a Buy rating following strong results.

... More